[Impact of antiangiogenic therapy on ocular blood flow and microcirculation in diabetic macular edema].

Unlabelled: Today, diabetic macular edema (DME) is still one of the main causes of vision loss in patients with diabetes.

Purpose: To identify changes in the ocular blood flow and microvascular network of the macular zone in patients with DME after antiangiogenic therapy.

Material And Methods: In the course of the study, 25 patients (50 eyes) with monolateral clinically significant DME aged 67.